Therapy of Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia

E-ISSN： 1873-4286|18|23|3399-3405

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.23, 2012-08, pp. : 3399-3405

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-10 ,pp. : 710-720

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic Lymphocytic Leukemia Therapy: Beyond Chemoimmunotherapy

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3356-3362

Bentham Science Publishers

Access to resources Recommend Favorite

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig Lamanna Nicole Weiss Mark A

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite

A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia

Current Medicinal Chemistry, Vol. 19, Iss. 31, 2012-11 ,pp. : 5294-5318

Bentham Science Publishers

Access to resources Recommend Favorite

FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia

Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. : 3494-3501

Blackwell Publishing

Access to resources Recommend Favorite